Incyte Corp. (INCY) Social Stream



Incyte Corp. (INCY): $71.05

0.49 (+0.69%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add INCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#14 of 332

in industry

Featured Post From StockTwits About INCY

$GILD $INCY $DMTK $ATNF
Good interview with ATNF Co-Founder Sir Marc Feldmann, who discovered Anti-TNF Biologics... The top selling drug class in the world (Remicade, Embrel, Humira,etc). He is one of the Top minds in Bioscience & Biotech. He joined other top Biotech minds to co-found the newly Public: 180 Life Sciences... $ATNF (to gain approval for unmet fibrosis conditions via Anti-TNF platform).. & to develop a new class of drugs (w/ equally brilliant Prof Rafael Mechoulam).. as a better treatment of arthritic conditions/ and with lower risk profiles & side effects.
https://youtu.be/WdrNPRuFTc8
SCNC, published August 6, 2021

What Else are INCY Traders Talking About?


Other tickers frequently mentioned alongside INCY are GILD, DMTK and ATNF.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!